NexSteppe Inc. CEO Selected to Receive the 2016 BIO Rosalind Franklin Award

The Biotechnology Innovation Organization (BIO) announced today that President and CEO of NexSteppe, Anna Rath, has been selected by a committee of her peers to be the recipient of the 2016 BIO Rosalind Franklin Award. 

BIO Statement on American College of Physicians’ Prescription Drug Plan

Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement today regarding the American College of Physicians’ policy paper on prescription drugs.

2016 BIO World Congress on Industrial Biotechnology Exhibition Hall to Feature NSF Small Business Innovation Research Companies

The Biotechnology Innovation Organization (BIO) in partnership with the National Science Foundation (NSF) will feature Small Business Innovation Research (SBIR) funded early-stage industrial biotech companies at BIO’s 13thAnnual World Congress on Industrial Biotechnology.  

BIO Announces Plenary Session Speakers for the 2016 World Congress on Industrial Biotechnology

The Biotechnology Innovation Organization (BIO) announces that executives, thought leaders, and government  officials will discuss applications in space, biofuels, and the renewable chemical landscape during plenary programs at BIO’s 13th Annual World Congress on Industrial Biotechnology

BIO Statement on FDA and NIH Workforce Authorities Modernization Act

Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood released the following statement regarding the introduction today by Senators Alexander and Murray of the FDA and NIH Workforce Authorities Modernization Act:

BIO & Kentucky Life Sciences Council Support Bill Ensuring Patient Access to Interchangeable Biologic Medicines

The Biotechnology Innovation Organization (BIO) andKentucky Life Sciences Council (KLSC) today voiced support for Kentucky Senate Bill 134, legislation that properly preserves patient and physician access to accurate prescription information, while promoting a competitive market for complex biologic medicines.

J. Craig Venter, Ph.D to Receive the 2016 BIO George Washington Carver Award

The Biotechnology Innovation Organization (BIO) has officially named Dr. J. Craig Venter as the recipient of its 2016 George Washington Carver Award for innovation in industrial biotechnology. 

BIO Applauds Iowa Senate Passage of Renewable Chemical Tax Credit

The Biotechnology Innovation Organization (BIO) today applauded Iowa’s Senate for approving a new five-year production tax credit for renewable chemicals and helping to drive innovation in this new sector. Renewable chemicals will be defined in Iowa’s tax code as having at least 50 percent biobased content and not being used as food, feed or fuel. The value of the tax credit is limited to $105 million over five years.

BIO Statement on Failure to Stop Patchwork of State GMO Labeling Laws

The U.S. Senate was unable to advance a national solution to GMO food labeling.  It is essential for Senate leaders to continue working to reach a much-needed compromise over the coming days, as failure to move forward allows costly and confusing state-based measures such as Vermont’s GMO food labeling law to take effect in July.

BIO’s comments to the USDA on the biomass crop assistance program enacted by the 2008 Farm Bill

Comments are regarding conservation and stewardship requirements, matching payments, establishment costs and annual payments, disclosure of competitively sensitive information, invasiveness determination and review, consistency with existing FSA programs, corporations and publicly traded company participation, eligible materials, and algae.